Regulus Therapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Regulus Therapeutics Inc. |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
TL;DR
Regulus Therapeutics filed an 8-K on May 8, 2025, for operational and financial updates.
AI Summary
Regulus Therapeutics Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational updates beyond the reporting of these standard sections.
Why It Matters
This 8-K filing indicates Regulus Therapeutics is providing updates on its financial condition and operations. Investors should review the full filing for details on any significant developments.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting operational and financial information, without immediate news of significant events.
Key Players & Entities
- Regulus Therapeutics Inc. (company) — Registrant
- May 8, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-35670 (identifier) — SEC File Number
- 26-4738379 (identifier) — IRS Employer Identification No.
- 4224 Campus Point Court, Suite 210, San Diego, CA 92121 (address) — Principal executive offices
- (858) 202-6300 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but specific figures or details are not provided in the provided text.
When was this 8-K report filed by Regulus Therapeutics Inc.?
The report was filed on May 8, 2025.
What is the principal business address of Regulus Therapeutics Inc.?
The principal executive offices are located at 4224 Campus Point Court, Suite 210, San Diego, CA 92121.
What is the SEC file number for Regulus Therapeutics Inc.?
The SEC file number is 001-35670.
What is the state of incorporation for Regulus Therapeutics Inc.?
Regulus Therapeutics Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Regulus Therapeutics Inc..